In homologous breast tumor models, pharmacologic inhibition of adipogenesis selectively decreased the generation of PD-L1 in mouse adipose tissue and improved the anti-tumor efficacy of anti-PD-L1 or anti-PD-1 antibodies [45]. This evidence concerns the gene CD274 and breast neoplasm.